Sequana Medical Agrees Loan Amendment with Kreos Capital

12:59 AM EST, 12/24/2025 (MT Newswires) -- Belgian medical device company Sequana Medical (SEQUA.BR) said Tuesday it agreed to amend the terms of its loan agreement with Kreos Capital VII. Under a nonbinding letter of intent, the companies agreed to extend the interest-only period and defer the amortization repayments until May 1, 2026. The first two monthly repayments of principal and interest will each amount to half of the regular monthly repayments due during the three months ahead of the final maturity on Sept. 1, 2026. The proposed amendments remain subject to the execution of a final binding agreement with Kreos.